|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 1. | Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth Thummel, Xiao-xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao, Lawrence J. Lesko | ||
| New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process | |||
|---|---|---|---|
|
J Clin Pharmacol Jun 01, 2008; 48: 662-670.
(In "Drug Interactions/Review") |
|||
| 2. | Carol Addy, Paul Rothenberg, Susie Li, Anup Majumdar, Nancy Agrawal, Hankun Li, Ling Zhong, Jinyu Yuan, Andrea Maes, Stephanie Dunbar, Josee Cote, Kim Rosko, Kristien Van Dyck, Inge De Lepeleire, Jan de Hoon, Anne Van Hecken, Marleen Depré, Annemie Knops, Keith Gottesdiener, Aubrey Stoch, John Wagner | ||
| Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers | |||
|
J Clin Pharmacol Jun 01, 2008; 48: 734-744.
(In "Pharmacokinetics and Pharmacodynamics") |
|||
| 3. | Amita Joshi, Robert Bauer, Peter Kuebler, Mark White, Cecelia Leddy, Peter Compton, Marvin Garovoy, Paul Kwon, Patricia Walicke, Russell Dedrick | ||
| An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis | |||
|
J Clin Pharmacol Jan 01, 2006; 46: 10-20.
(In "Therapeutic Review") |
|||
| 4. | J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala, Steven A. Wrighton | ||
| PhRMA White Paper on ADME Pharmacogenomics | |||
|
J Clin Pharmacol Jun 04, 2008; doi: 10.1177/0091270008319329.
(In "Articles") |
|||
| 5. | Jules I. Schwartz, Aimee L. Dallob, Patrick J. Larson, Omar F. Laterza, Jutta Miller, Jane Royalty, Karen M. Snyder, Derek L. Chappell, Deborah A. Hilliard, Mary E. Flynn, Paul F. Cavanaugh, John A. Wagner | ||
| Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects | |||
|
J Clin Pharmacol Jun 01, 2008; 48: 745-754.
(In "Pharmacodynamics") |
|||
| [Next 5 Articles] | |||
= from the current issue
Last Updated: 07/03/2008 04:03:16
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |